Status: Not yet recruiting
Analysis of the Presence and Cardiac Functional Effects of Anti-NaV1.5 Autoantibodies in Patients With Metastatic Tumors
The overall aim of this study is to identify and characterize anti-NaV1.5 autoantibodies in patients with metastatic breast and colorectal cancer. These tumors are characterized by the presence of a specific target structure (called nNaV1.5) against which antibodies are produced. These antibodies may cross-react with a similar structure (called NaV1.5) that is found in the heart. This could affect channel function and increase the risk of arrhythmias.
Participants needed: 196
Trial details
Biological sex: AllType: InterventionalSponsor: IRCCS Policlinico S. DonatoUpdated: Jan 23, 2026Locations: 1
Eligibility criteria
Age ≥ 18 years [+3]
Clinically significant cardiovascular diseases (atrial fibrillation, congestive... [+2]